Not applicableStudy completedNCT03662048What this trial is testingImproving Infant Sleep Safety With the Electronic Health RecordWho this might be right forSIDSInfant Development Milton S. Hershey Medical Center 130
Not applicableStudy completedNCT02039583What this trial is testingImpact of Smoke-free Legislation on Early-life Mortality and Low Birth Weight in EnglandWho this might be right forStillbirthInfant MortalitySudden Infant Death+2 more University of Edinburgh 10,291,118
Not applicableLooking for participantsNCT03333200What this trial is testingLongitudinal Study of Neurodegenerative DisordersWho this might be right forMLDKrabbe DiseaseALD+24 more University of Pittsburgh 1,500
Large-scale testing (Phase 3)Looking for participantsNCT05371613What this trial is testingDetermine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)Who this might be right forMucopolysaccharidosis II Denali Therapeutics Inc. 63
Not applicableStudy completedNCT00004392What this trial is testingIncidence and Severity of Cardiorespiratory Events in Infants at Increased Epidemiological Risk for Sudden Infant Death Syndrome (SIDS)Who this might be right forSudden Infant Death SyndromeApnea Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 900
Large-scale testing (Phase 3)Study completedNCT02040935What this trial is testingSC Administration of Trastuzumab (Herceptin) by SID at Home in HER2-Positive EBC ParticipantsWho this might be right forBreast Cancer Hoffmann-La Roche 128
Large-scale testing (Phase 3)Ended earlyNCT00654433What this trial is testingALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic DiseasesWho this might be right forInherited Metabolic DiseasesLysosomal Storage DisordersPeroxisomal Storage Diseases+2 more Aldagen 40
Not applicableNot Yet RecruitingNCT07037914What this trial is testingThe Impact of the Nurse-Led "My Baby is Safe" Educational ProgramWho this might be right forSudden Infant Death SyndromeShaken Baby Syndrome Amasya University 50
Not applicableStudy completedNCT03392727What this trial is testingEvaluation of Safe Sleep for Babies: a Bassinet Distribution and Education ProgramWho this might be right forSudden Infant Death University of Manitoba 30
Not applicableStudy completedNCT01265277What this trial is testingChanges in Sleep Patterns and Stress in Infants Entering Child CareWho this might be right forSudden Infant Death Syndrome Rachel Moon, MD 20
Not applicableActive Not RecruitingNCT06708793What this trial is testingEnvironmental Exposures and Sudden Unexpected Infant DeathWho this might be right forSudden Unexpected Infant Death, Air Pollution, Pesticides Nantes University Hospital 100
Not applicableStudy completedNCT04387552What this trial is testingSocial Media and Risk Reduction Teaching-Enhanced ReachWho this might be right forBreastfeedingSUIDSIDS Boston University 2,126
Not applicableStudy completedNCT01938014What this trial is testingLysosomal Storage Disease: Health, Development, and Functional Outcome Surveillance in Preschool ChildrenWho this might be right forMucopolysaccharidosis Type I (MPS I)Mucopolysaccharidosis Type II (MPS II)Mucopolysaccharidosis Type III (MPS III)+2 more University of Chicago 19
Large-scale testing (Phase 3)Active Not RecruitingNCT07236606What this trial is testingRGX-121-3102 Gene Therapy in Participants With MPS II (Hunter Syndrome)Who this might be right forMPS IIHunter Syndrome (MPS II) REGENXBIO Inc. 2
Large-scale testing (Phase 3)Study completedNCT03689972What this trial is testingEvaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab AdministrationWho this might be right forMultiple Sclerosis, Relapsing-Remitting Biogen 585
Testing effectiveness (Phase 2)Study completedNCT01301898What this trial is testingTo Evaluate the Safety and Efficacy of GC1111 (Recombinant Human Iduronate-2-sulfatase) in Hunter Syndrome PatientsWho this might be right forMucopolysaccharidosis II Green Cross Corporation 31
Not applicableStudy completedNCT07032402What this trial is testingThe Effect of the Use of Mobile AppWho this might be right forSudden Infant Death Syndrome Amasya University 40
Large-scale testing (Phase 3)Study completedNCT02194166What this trial is testingInvestigate the Tolerability of Subcutaneous (SC) Trastuzumab Administration in Participants With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Early Breast Cancer (eBC) Using Either a Single-Use Injection Device or Manual AdministrationWho this might be right forBreast Cancer Hoffmann-La Roche 90
Not applicableLooking for participantsNCT06821880What this trial is testingDeveloping a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID ProjectWho this might be right forChronic Lymphocytic Leukaemia (CLL)Multiple Myeloma (MM)Secondary Immunodeficiency (SID) Medical University Innsbruck 120
Not applicableStudy completedNCT01361880What this trial is testingReduce African-American Infant MortalityWho this might be right forHealth Behavior University of Virginia 1,200